Welsh success in Advanced Therapy Treatment Centre bid
A joint bid involving the Welsh Blood Service, Velindre NHS Trust and TrakCel has been successful in securing a £7m grant from Innovate UK to fund a Midlands and Wales Advanced Therapy Treatment Centre.
The Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC) project is led by the Birmingham Biomedical Research Centre and a consortium involving the NHS, companies and universities covers the Midlands and Wales giving access to almost 15 million people, providing a unique opportunity to set cell therapy up to succeed.
The bid faced tough competition for funds as only three treatment centres are being supported across the UK.
Advanced Therapy Medicinal Products (ATMP), which can be cell or gene therapies, show great potential in treating patients with conditions that cannot be cured with current treatments. These include arthritis, liver disease, several types of cancer, and diabetic ulcers.